BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-01-30
• Last 15 days FTD volume: $0.34 M
• Last 3 months FTD volume: $0.76 M
• Last 12 months FTD volume: $5.17 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	$20.51 M	$0.24 B	🇺🇸 USA
GSK plc GSK	$23.88 M	$0.36 B	🇬🇧 UK
Sarepta Therapeutics SRPT	$3.87 M	$21.35 M	🇺🇸 USA
Repligen RGEN	$7.32 M	$22.33 M	🇺🇸 USA
Novavax NVAX	$18.77 M	$66.18 M	🇺🇸 USA
Celldex Therapeutics CLDX	$6.19 M	$10.74 M	🇺🇸 USA
NanoViricides NNVC	$0.65 M	$4.21 M	🇺🇸 USA
Cel-Sci CVM	N/A	$0.36 M	🇺🇸 USA
Emergent BioSolutions EBS	$0.46 M	$4.34 M	🇺🇸 USA